UNSPSC 51162412: Dextromethorphan/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE512. This VA Drug Class (RE512) classifies this compound as belonging to the group DECONGESTANT/ANTITUSSIVE.

UNSPSC 51162412 Dextromethorphan/pseudoephedrine is a Commodity code nominally tracking a specific cold-remedy active ingredient, but recent state and local opportunities under this code show minimal direct relevance. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 seeks generic multi-source pharmaceuticals and OTC products broadly—a wide net that may incidentally include dextromethorphan formulations but is organized by drug classification and NDC code rather than active-ingredient targeting. The Seminole County, Florida IFB 60459723LAS solicits naloxone and drug deactivation systems, which falls outside the code's scope entirely. State and local issuers under this code span health departments and cooperative purchasing vehicles, with MMCAP representing multistate participation across Minnesota, Oregon, and participating jurisdictions. The actual buying pattern shows a preference for bundled pharmaceutical procurement through authorized wholesalers and health system distribution channels rather than point-of-use or single-ingredient sourcing.

Geographic activity centers on Minnesota through MMCAP's multistate cooperative model and Florida through Seminole County's county-level health procurement. The MMCAP RFP (posted January 20, 2026, due March 26, 2026) is the more relevant recent opportunity, requiring manufacturers to supply generic pharmaceuticals with NDC codes, comply with cGMP and Drug Supply Chain Security Act certification, maintain relationships with AmerisourceBergen Drug Corporation, Cardinal Health, or Morris & Dickson wholesalers, and accept a 3 percent administrative fee. Pricing is weighted at 75 percent of evaluation, with contract effectiveness set for July 1, 2026. The Seminole County solicitation (posted June 30, 2026, due July 26, 2023—a date discrepancy in the source) addresses a narrower, unrelated need. For firms pursuing work under this code, MMCAP cooperative purchasing represents the substantive opportunity; standalone dextromethorphan procurement shows limited recent state and local solicitation activity.